(Q51856713)

14 April 2018

title

Antimicrobial stewardship in the intensive care unit: advances and obstacles. (English)

1 reference

14 April 2018

1 reference

2

Marin H Kollef

1 reference

14 April 2018

Kevin L Lawrence

1

1 reference

14 April 2018

language of work or name

English

0 references

publication date

8 January 2009

1 reference

14 April 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

14 April 2018

volume

179

1 reference

14 April 2018

issue

6

1 reference

14 April 2018

page(s)

434-438

1 reference

14 April 2018

Hospital antibiotic stewardship

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Antimicrobial stewardship: concepts and strategies in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Antimicrobial stewardship programs: interventions and associated outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Prediction of specific pathogens in patients with sepsis: evaluation of TREAT, a computerized decision support system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Pilot study of a web-based antibiotic decision management guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

The importance of early treatment with doxycycline in human ehrlichiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Plasticity of the systemic inflammatory response to acute infection during critical illness: development of the riboleukogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Gene expression patterns in blood leukocytes discriminate patients with acute infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Hepatitis C virus infection in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Preemptive antifungal therapy: still a way to go.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Rapid identification of penicillin and macrolide resistance genes and simultaneous quantification of Streptococcus pneumoniae in purulent sputum samples by use of a novel real-time multiplex PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Direct detection of methicillin-resistant Staphylococcus aureus in clinical specimens by a nucleic acid-based hybridisation assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

Galactomannan in Bronchoalveolar Lavage Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200809-1394CP

10.1164/RCCM.200809-1394CP

21 January 2018

Identifiers

DOI

1 reference

14 April 2018

1 reference

14 April 2018